APPSWE-Tau Publications

APPSWE-Tau Model Page

Filter publications by application: All Alzheimer's Metabolism Neuroscience
Filter publications by model type: All Humanization



Paper Title


Model Type


Full Text

King MR, et al.
Mouse over for full list
King MR, Anderson NJ, Deciu M, Guernsey LS, Cundiff M, Hajizadeh S, Jolivalt CG
(2020) Insulin deficiency, but not resistance, exaggerates cognitive deficits in transgenic mice expressing human amyloid and tau proteins. Reversal by Exendin-4 treatment. J Neurosci Res 98(11):2357-2369
Metabolism, Alzheimer's
Marquez A, et al.
Mouse over for full list
Marquez A, Guernsey LS, Frizzi KE, Cundiff M, Constantino I, Muttalib N, Arenas F, Zhou X, Lim SH, Ferdousi M, Ponirakis G, Silverdale M, Kobylecki C, Jones M, Marshall A, Malik RA, Jolivalt CG
(2021) Tau associated peripheral and central neurodegeneration: Identification of an early imaging marker for tauopathy. Neurobiol Dis 151:105273
Neuroscience, Alzheimer's
Bitner RS, et al.
Mouse over for full list
Bitner RS, Markosyan S, Nikkel AL, Brioni JD
(2011) In-vivo histamine H3 receptor antagonism activates cellular signaling suggestive of symptomatic and disease modifying efficacy in Alzheimer's disease. Neuropharmacology 60(2-3):460-6
Neuroscience, Alzheimer's
Saydoff JA, et al.
Mouse over for full list
Saydoff JA, Olariu A, Sheng J, Hu Z, Li Q, Garcia R, Pei J, Sun GY, von Borstel R
(2013) Uridine prodrug improves memory in Tg2576 and TAPP mice and reduces pathological factors associated with Alzheimer's disease in related models. J. Alzheimers Dis. 36(4):637-57
Neuroscience, Alzheimer's
Fukuhara K, et al.
Mouse over for full list
Fukuhara K, Ohno A, Ota Y, Senoo Y, Maekawa K, Okuda H, Kurihara M, Okuno A, Niida S, Saito Y, Takikawa O
(2013) NMR-based metabolomics of urine in a mouse model of Alzheimer's disease: identification of oxidative stress biomarkers. J Clin Biochem Nutr 52(2):133-8
Neuroscience, Alzheimer's
Yuzwa SA, et al.
Mouse over for full list
Yuzwa SA, Shan X, Jones BA, Zhao G, Woodward ML, Li X, Zhu Y, McEachern EJ, Silverman MA, Watson NV, Gong CX, Vocadlo DJ
(2014) Pharmacological inhibition of O-GlcNAcase (OGA) prevents cognitive decline and amyloid plaque formation in bigenic tau/APP mutant mice. Mol Neurodegener 9:42
Neuroscience, Alzheimer's
Goncalves MB, et al.
Mouse over for full list
Goncalves MB, Clarke E, Hobbs C, Malmqvist T, Deacon R, Jack J, Corcoran JP
(2013) Amyloid β inhibits retinoic acid synthesis exacerbating Alzheimer disease pathology which can be attenuated by an retinoic acid receptor α agonist. Eur. J. Neurosci. 37(7):1182-92
Neuroscience, Alzheimer's
Lewis J, et al.
Mouse over for full list
Lewis J, Dickson DW, Lin WL, Chisholm L, Corral A, Jones G, Yen SH, Sahara N, Skipper L, Yager D, Eckman C, Hardy J, Hutton M, McGowan E
(2001) Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 293(5534):1487-91
Neuroscience, Alzheimer's
Sahara N, et al.
Mouse over for full list
Sahara N, Vega IE, Ishizawa T, Lewis J, McGowan E, Hutton M, Dickson D, Yen SH
(2004) Phosphorylated p38MAPK specific antibodies cross-react with sarkosyl-insoluble hyperphosphorylated tau proteins. J. Neurochem. 90(4):829-38
Neuroscience, Alzheimer's
Ishizawa T, et al.
Mouse over for full list
Ishizawa T, Sahara N, Ishiguro K, Kersh J, McGowan E, Lewis J, Hutton M, Dickson DW, Yen SH
(2003) Co-localization of glycogen synthase kinase-3 with neurofibrillary tangles and granulovacuolar degeneration in transgenic mice. Am. J. Pathol. 163(3):1057-67
Neuroscience, Alzheimer's

Welcome! Tell us a little about yourself